11-2406692-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014555.4(TRPM5):c.3220G>A(p.Glu1074Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,613,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014555.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRPM5 | NM_014555.4 | c.3220G>A | p.Glu1074Lys | missense_variant | 26/29 | ENST00000696290.1 | NP_055370.1 | |
TRPM5 | XM_017017628.2 | c.3274G>A | p.Glu1092Lys | missense_variant | 23/26 | XP_016873117.1 | ||
TRPM5 | XM_047426858.1 | c.3274G>A | p.Glu1092Lys | missense_variant | 23/26 | XP_047282814.1 | ||
TRPM5 | XM_047426859.1 | c.2071G>A | p.Glu691Lys | missense_variant | 14/17 | XP_047282815.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152254Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460794Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 726672
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152254Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 06, 2024 | The c.3220G>A (p.E1074K) alteration is located in exon 21 (coding exon 21) of the TRPM5 gene. This alteration results from a G to A substitution at nucleotide position 3220, causing the glutamic acid (E) at amino acid position 1074 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at